Home > Research > Publications & Outputs > A proposal for a new PhD level curriculum on qu...

Research

Associated organisational units

Electronic data

  • IDEAS_paper_revision_V2_clean

    Accepted author manuscript, 458 KB, PDF document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

Links

Text available via DOI:

Keywords

View graph of relations

A proposal for a new PhD level curriculum on quantitative methods for drug development

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

A proposal for a new PhD level curriculum on quantitative methods for drug development. / Jaki, Thomas Friedrich; Gordon, A; Forster, Pamela Suzanne et al.
In: Pharmaceutical Statistics, Vol. 17, No. 5, 09.2018, p. 593-606.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Jaki, TF, Gordon, A, Forster, PS, Bijnens, L, Bornkamp, B, Brannath, W, Fontana, R, Gasparini, M, Hampson, LV, Jacobs, T, Jones, B, Paoletti, X, Posch, M, Titman, AC, Vonk, R & Koenig, F 2018, 'A proposal for a new PhD level curriculum on quantitative methods for drug development', Pharmaceutical Statistics, vol. 17, no. 5, pp. 593-606. https://doi.org/10.1002/pst.1873

APA

Jaki, T. F., Gordon, A., Forster, P. S., Bijnens, L., Bornkamp, B., Brannath, W., Fontana, R., Gasparini, M., Hampson, L. V., Jacobs, T., Jones, B., Paoletti, X., Posch, M., Titman, A. C., Vonk, R., & Koenig, F. (2018). A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics, 17(5), 593-606. https://doi.org/10.1002/pst.1873

Vancouver

Jaki TF, Gordon A, Forster PS, Bijnens L, Bornkamp B, Brannath W et al. A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics. 2018 Sept;17(5):593-606. Epub 2018 Jul 9. doi: 10.1002/pst.1873

Author

Jaki, Thomas Friedrich ; Gordon, A ; Forster, Pamela Suzanne et al. / A proposal for a new PhD level curriculum on quantitative methods for drug development. In: Pharmaceutical Statistics. 2018 ; Vol. 17, No. 5. pp. 593-606.

Bibtex

@article{f5b77f7ed88944ba9dd663e2c7edb627,
title = "A proposal for a new PhD level curriculum on quantitative methods for drug development",
abstract = "This paper provides an overview of “Improving Design, Evaluation and Analysis of early drug development Studies” (IDEAS), a European Commission–funded network bringing together leading academic institutions and small‐ to large‐sized pharmaceutical companies to train a cohort of graduate‐level medical statisticians. The network is composed of a diverse mix of public and private sector partners spread across Europe, which will host 14 early‐stage researchers for 36 months. IDEAS training activities are composed of a well‐rounded mixture of specialist methodological components and generic transferable skills. Particular attention is paid to fostering collaborations between researchers and supervisors, which span academia and the private sector. Within this paper, we review existing medical statistics programmes (MSc and PhD) and highlight the training they provide on skills relevant to drug development. Motivated by this review and our experiences with the IDEAS project, we propose a concept for a joint, harmonised European PhD programme to train statisticians in quantitative methods for drug development.",
keywords = "development of early‐stage researchers , drug development, PhD curriculum , regulatory statistics, university‐industry partnership",
author = "Jaki, {Thomas Friedrich} and A Gordon and Forster, {Pamela Suzanne} and L Bijnens and B Bornkamp and Werner Brannath and Roberto Fontana and Mauro Gasparini and Hampson, {Lisa Victoria} and Tom Jacobs and Byron Jones and Xavier Paoletti and Martin Posch and Titman, {Andrew Charles} and Richardus Vonk and Franz Koenig",
year = "2018",
month = sep,
doi = "10.1002/pst.1873",
language = "English",
volume = "17",
pages = "593--606",
journal = "Pharmaceutical Statistics",
issn = "1539-1604",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - A proposal for a new PhD level curriculum on quantitative methods for drug development

AU - Jaki, Thomas Friedrich

AU - Gordon, A

AU - Forster, Pamela Suzanne

AU - Bijnens, L

AU - Bornkamp, B

AU - Brannath, Werner

AU - Fontana, Roberto

AU - Gasparini, Mauro

AU - Hampson, Lisa Victoria

AU - Jacobs, Tom

AU - Jones, Byron

AU - Paoletti, Xavier

AU - Posch, Martin

AU - Titman, Andrew Charles

AU - Vonk, Richardus

AU - Koenig, Franz

PY - 2018/9

Y1 - 2018/9

N2 - This paper provides an overview of “Improving Design, Evaluation and Analysis of early drug development Studies” (IDEAS), a European Commission–funded network bringing together leading academic institutions and small‐ to large‐sized pharmaceutical companies to train a cohort of graduate‐level medical statisticians. The network is composed of a diverse mix of public and private sector partners spread across Europe, which will host 14 early‐stage researchers for 36 months. IDEAS training activities are composed of a well‐rounded mixture of specialist methodological components and generic transferable skills. Particular attention is paid to fostering collaborations between researchers and supervisors, which span academia and the private sector. Within this paper, we review existing medical statistics programmes (MSc and PhD) and highlight the training they provide on skills relevant to drug development. Motivated by this review and our experiences with the IDEAS project, we propose a concept for a joint, harmonised European PhD programme to train statisticians in quantitative methods for drug development.

AB - This paper provides an overview of “Improving Design, Evaluation and Analysis of early drug development Studies” (IDEAS), a European Commission–funded network bringing together leading academic institutions and small‐ to large‐sized pharmaceutical companies to train a cohort of graduate‐level medical statisticians. The network is composed of a diverse mix of public and private sector partners spread across Europe, which will host 14 early‐stage researchers for 36 months. IDEAS training activities are composed of a well‐rounded mixture of specialist methodological components and generic transferable skills. Particular attention is paid to fostering collaborations between researchers and supervisors, which span academia and the private sector. Within this paper, we review existing medical statistics programmes (MSc and PhD) and highlight the training they provide on skills relevant to drug development. Motivated by this review and our experiences with the IDEAS project, we propose a concept for a joint, harmonised European PhD programme to train statisticians in quantitative methods for drug development.

KW - development of early‐stage researchers

KW - drug development

KW - PhD curriculum

KW - regulatory statistics

KW - university‐industry partnership

U2 - 10.1002/pst.1873

DO - 10.1002/pst.1873

M3 - Journal article

VL - 17

SP - 593

EP - 606

JO - Pharmaceutical Statistics

JF - Pharmaceutical Statistics

SN - 1539-1604

IS - 5

ER -